Delisting risk
Bionano Genomics
Optical genome mapping systems, software and consumables for structural-variation analysis.
$1.17
After-hours close0.00 (0.00%)
At close$1.17(−3.31%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 7.59%870.7K sharesInsiders 0.07%7.7K sharesOther 92.34%10.60M shares
Shares outstanding 11.48M · Float 10.78M · 94.0% free float
Institutions13F, as of Mar 31, 2026
31 holders · 870.7K shares · 10 new positions · 19 increased · 3 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Gsa Capital Partners LLP | 353.4K | 3.08% | +15.6K | May 8, 2026 |
| Geode Capital Management, LLC | 167.5K | 1.46% | +100.8K | May 15, 2026 |
| Carret Asset Management, LLC | 70.0K | 0.61% | +25.9K | May 15, 2026 |
| Vanguard Capital Management LLC | 68.1K | 0.59% | +68.1Knew | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 51.6K | 0.45% | +51.6Knew | May 8, 2026 |
| Renaissance Technologies LLC | 48.7K | 0.42% | +11.7K | May 14, 2026 |
| Prudential Financial Inc | 28.0K | 0.24% | +28.0Knew | May 13, 2026 |
| Northern Trust Corp | 20.5K | 0.18% | 0 | May 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Ayrton Capital LLC | 9.99% | 528.2K | 13G | Nov 13, 2025 ↗ |
| CVI Investments, Inc. | 9.90% | 1.13M | 13G | Feb 17, 2026 ↗ |
| Lind Global Fund III LP | 9.35% | 1.05M | 13G | Feb 17, 2026 ↗ |
| Lincoln Alternative Strategies LLC | 5.42% | 525.0K | 13G | Sep 17, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Albert Luderer | director, officer: Interim Chief Executive | 4.0K | 0.03% | Aug 21, 2026 |
| R. Erik Holmlin | director, officer: PRESIDENT AND CEO | 1.7K | 0.01% | Feb 18, 2026 |
| Mark Oldakowski | officer: CHIEF OPERATING OFFICER | 868 | 0.01% | Jun 3, 2026 |
| Alka Chaubey | officer: CHIEF MEDICAL OFFICER | 620 | 0.01% | Jun 3, 2026 |
| Mark Adamchak | officer: Principal Accounting Officer | 253 | 0.00% | Jun 3, 2026 |
| Jonathan V. Dixon | officer: GENERAL COUNSEL | 239 | 0.00% | Jun 3, 2026 |
| Alex Reid Hastie | officer: Chief Scientific Officer | 63 | 0.00% | Jul 30, 2026 |
6 ten-percent owners hold 4.8K shares by Form 4, outside the officers-and-directors figure above · 10 people have not refiled in the last 18 months (10.6K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | Albert Ludererdirector, officer: Interim Chief Executive | Purchase | 4,000 | $1.22 | 4,000 |
CongressHouse and Senate disclosures
Not reported.